Zhenyu Gui, Xiaoda Yang, Hao Chen, Jing Zhuang, Ping Lan
{"title":"Adsorption of Blood Creatinine on a Heparin-Functionalized Surface of Copper-Based Metal-Organic Frameworks.","authors":"Zhenyu Gui, Xiaoda Yang, Hao Chen, Jing Zhuang, Ping Lan","doi":"10.1002/1744-9987.70122","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Creatinine accumulation exacerbates outcomes in chronic kidney disease (CKD). To enhance creatinine removal and improve hemocompatibility, we developed heparin-functionalized copper-based metal-organic frameworks (CuMOFs-Hep).</p><p><strong>Methods: </strong>CuMOFs were heparinized via APTES bridging and characterized (XRD, SEM, FTIR, XPS, and zeta potential). Adsorption was evaluated in simulated CKD serum and was fitted with isotherm models. Whole-blood samples from patients/healthy donors were tested. Biosafety was assessed by Cu<sup>2+</sup> leaching and platelet assays.</p><p><strong>Results: </strong>Heparinization increased surface negative charge and raised the maximum capacity to 267.8 mg g<sup>-1</sup> (68.7% over pristine; Langmuir R <sup>2</sup> = 0.983). Adsorption kinetics studies indicate rapid clearance of creatinine, achieving a clearance rate of 65.9% within 30 min at 37°C and reaching 75.0% within 2 h. In patient blood (854.2 μmol/L), supernatant creatinine decreased to 163.2 μmol/L (80.9% removal). Cu<sup>2+</sup> leaching dropped to 0.214 ppm (-89.9%), with reduced platelet adhesion/activation.</p><p><strong>Conclusion: </strong>CuMOFs-Hep enables efficient, low-leaching creatinine adsorption in clinically relevant matrices, highlighting its promising potential as an efficient adsorbent for blood purification applications.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"363-370"},"PeriodicalIF":1.2000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/1744-9987.70122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Creatinine accumulation exacerbates outcomes in chronic kidney disease (CKD). To enhance creatinine removal and improve hemocompatibility, we developed heparin-functionalized copper-based metal-organic frameworks (CuMOFs-Hep).
Methods: CuMOFs were heparinized via APTES bridging and characterized (XRD, SEM, FTIR, XPS, and zeta potential). Adsorption was evaluated in simulated CKD serum and was fitted with isotherm models. Whole-blood samples from patients/healthy donors were tested. Biosafety was assessed by Cu2+ leaching and platelet assays.
Results: Heparinization increased surface negative charge and raised the maximum capacity to 267.8 mg g-1 (68.7% over pristine; Langmuir R 2 = 0.983). Adsorption kinetics studies indicate rapid clearance of creatinine, achieving a clearance rate of 65.9% within 30 min at 37°C and reaching 75.0% within 2 h. In patient blood (854.2 μmol/L), supernatant creatinine decreased to 163.2 μmol/L (80.9% removal). Cu2+ leaching dropped to 0.214 ppm (-89.9%), with reduced platelet adhesion/activation.
Conclusion: CuMOFs-Hep enables efficient, low-leaching creatinine adsorption in clinically relevant matrices, highlighting its promising potential as an efficient adsorbent for blood purification applications.